Table 4.
Associations of changes in bone turnover markers and bone parameters with changes in body composition measures, sex steroids, and enteric peptides over 12-months in cohort with female participants only
12-month change | BMI | Lean Mass | Estrone | FAI | Sclerostin | Ghrelin |
---|---|---|---|---|---|---|
ρ | ρ | ρ | ρ | ρ | ρ | |
Bone turnover markers | ||||||
P1NP | –0.455 * , a | –0.251 | –0.042 | 0.060 | 0.546 * | –0.306 |
CTX | –0.559 * , a | –0.571 * , a | –0.173 | –0.112 | 0.401 * , a | –0.423 * , a |
DXA | ||||||
LS BMD Z-scores | 0.212 | 0.202 | 0.170 | 0.342 * | –0.089 | 0.198 |
Total hip BMD Z-scores | 0.699 * , a | 0.735 * , a | 0.387 * , a | 0.425 * , a | –0.165a | 0.358 * |
FN BMD Z-scores | 0.463 * , a | 0.502 * , a | 0.257a | 0.089 | –0.052 | 0.352 * , a |
Whole body BMD Z-scores | –0.273 | –0.063 | 0.147 | 0.163 | –0.005 | 0.024 |
HRpQCT | ||||||
Radius | ||||||
Total vBMD | 0.404 * , a | 0.277 | 0.263 | –0.000 | 0.043 | 0.070 |
Cortical vBMD | –0.105 | –0.252 | 0.098 | 0.058 | 0.076 | –0.287 |
Trab vBMD | 0.617 * , a | 0.424 * , a | 0.128 | –0.013 | –0.100 | 0.341 a |
Failure load | 0.156 | 0.040 | 0.111 | 0.220 | –0.050 | 0.222 |
Tibia | ||||||
Total vBMD | 0.342 * , a | 0.285 | 0.221 | 0.085a | –0.217 | 0.280 |
Cortical vBMD | –0.113 | –0.142 | –0.095 | –0.350 * | –0.380 * | 0.068 |
Trabecular vBMD | –0.034 | –0.086 | 0.215 | 0.053a | –0.057 | 0.012 |
Failure load | 0.109 | 0.091 | 0.257 | –0.110 | –0.138 | –0.012 |
Spearman correlations (ρ) are reported.
Abbreviations: BMI, body mass index; BMD, bone mineral density; FAI, free androgen Index; P1NP, N-terminal propeptide of type 1 procollagen; CTX, C-terminal cross-linking telopeptide; LS, lumbar spine; FN, femoral neck; vBMD, volumetric bone mineral density.
*P < 0.05 (also in bold);
a P < .05 after controlling for baseline age and race.